Literature DB >> 19077468

Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.

Xiaohua Jiang1, Ivane Abiatari, Bo Kong, Mert Erkan, Tiago De Oliveira, Nathalia A Giese, Christoph W Michalski, Helmut Friess, Jörg Kleeff.   

Abstract

AIMS: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticins have been identified as tissue-specific angiogenic factors. This study investigates the expression and localization of EG-VEGF and its receptors in pancreatic tissues and pancreatic stellate cells (PSCs).
METHODS: mRNA levels of EG-VEGF/prokineticin 1 (PK1), prokineticin 2 (PK2) and their receptors 1 (PKR1) and 2 (PKR2) were measured in pancreatic tissues, pancreatic cancer cell lines and PSCs by quantitative reverse-transcriptase polymerase chain reaction (QRT-PCR). Protein expression of PK1, PKR1 and PKR2 was assessed in pancreatic tissues by immunohistochemistry. Growth factor-induced secretion of EG-VEGF was measured by ELISA.
RESULTS: QRT-PCR analysis in bulk tissues of normal pancreas, chronic pancreatitis and pancreatic ductal adenocarcinoma showed no significant difference of PK1 mRNA levels, whereas PK2 mRNA was barely detectable. High PK1 mRNA levels were observed only in cultured PSCs and microdissected islet cells, but not in cancer cells, and PK1 protein was localized mainly in islets and cancer-associated stromal cells. PKR1 and PKR2 proteins were present in endothelial cells of small blood vessels. TGF-beta(1) and PDGF-BB specifically stimulated PK1 secretion in PSCs.
CONCLUSIONS: Islet and/or PSC-derived PK1 might act through its receptors on endothelial cells to increase angiogenesis in pancreatic diseases. Copyright 2008 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077468     DOI: 10.1159/000178888

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  18 in total

Review 1.  The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.

Authors:  Cecilia Martin; Ravikumar Balasubramanian; Andrew A Dwyer; Margaret G Au; Yisrael Sidis; Ursula B Kaiser; Stephanie B Seminara; Nelly Pitteloud; Qun-Yong Zhou; William F Crowley
Journal:  Endocr Rev       Date:  2010-10-29       Impact factor: 19.871

Review 2.  The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.

Authors:  Mert Erkan; Simone Hausmann; Christoph W Michalski; Alexander A Fingerle; Martin Dobritz; Jörg Kleeff; Helmut Friess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 46.802

3.  Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype.

Authors:  Tiago De Oliveira; Ivane Abiatari; Susanne Raulefs; Danguole Sauliunaite; Mert Erkan; Bo Kong; Helmut Friess; Christoph W Michalski; Jörg Kleeff
Journal:  Mol Cancer       Date:  2012-04-03       Impact factor: 27.401

4.  Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment.

Authors:  Pradyut K Paul; Rahul Das; Travis J Drow; Arnaldo H de Souza; Appakalai N Balamurugan; Dawn Belt Davis; Jacques Galipeau
Journal:  Stem Cells Transl Med       Date:  2022-06-22       Impact factor: 7.655

5.  Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors.

Authors:  Dorothee Heck; Sebastian Wortmann; Luitgard Kraus; Cristina L Ronchi; Richard O Sinnott; Martin Fassnacht; Silviu Sbiera
Journal:  Horm Cancer       Date:  2015-12       Impact factor: 3.869

Review 6.  Role of pancreatic stellate cells in chemoresistance in pancreatic cancer.

Authors:  Joshua A McCarroll; Stephanie Naim; George Sharbeen; Nelson Russia; Julia Lee; Maria Kavallaris; David Goldstein; Phoebe A Phillips
Journal:  Front Physiol       Date:  2014-04-09       Impact factor: 4.566

7.  Growth factor mediated signaling in pancreatic pathogenesis.

Authors:  Debashis Nandy; Debabrata Mukhopadhyay
Journal:  Cancers (Basel)       Date:  2011-02-24       Impact factor: 6.639

8.  Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.

Authors:  Carolina Torres; Ana Linares; Maria José Alejandre; Rogelio J Palomino-Morales; Octavio Caba; Jose Prados; Antonia Aránega; Juan R Delgado; Antonio Irigoyen; Joaquina Martínez-Galán; Francisco M Ortuño; Ignacio Rojas; Sonia Perales
Journal:  Biomed Res Int       Date:  2015-08-04       Impact factor: 3.411

9.  Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.

Authors:  Dong Tang; Jingqiu Zhang; Zhongxu Yuan; Jun Gao; Sen Wang; Nianyuan Ye; Ping Li; Sujun Gao; Yi Miao; Daorong Wang; Kuirong Jiang
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes.

Authors:  Mara Castelli; Giada Amodeo; Lucia Negri; Roberta Lattanzi; Daniela Maftei; Cecilia Gotti; Francesco Pistillo; Valentina Onnis; Cenzo Congu; Alberto E Panerai; Paola Sacerdote; Silvia Franchi
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.